Unichem Laboratories Limited (UNICHEMLAB.NS)
INR 746.9
(-1.82%)
INR 746.9
(-1.82%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 16.57 Billion | 13.43 Billion | 12.47 Billion | 11.89 Billion | 11.56 Billion | 11.22 Billion |
| Cost of Revenue | 11.7 Billion | 5.5 Billion | 4.4 Billion | 4.01 Billion | 4.09 Billion | 4.67 Billion |
| Gross Profit | 4.86 Billion | 7.92 Billion | 8.07 Billion | 7.88 Billion | 7.47 Billion | 6.55 Billion |
| Operating Expenses | 6.72 Billion | 9.81 Billion | 8.18 Billion | 7.81 Billion | 8.77 Billion | 7.91 Billion |
| Selling, General and Administrative Expenses | 4.42 Billion | 1.62 Billion | 1.53 Billion | 1.58 Billion | 2.72 Billion | 2.31 Billion |
| Research and Development Expenses | 1.04 Billion | 263.93 Million | 337.56 Million | 439.02 Million | 1.56 Billion | 1.16 Billion |
| Other Expenses | - | 385.15 Million | 5.14 Million | 50.63 Million | 7.22 Million | 26.15 Million |
| Cost and Expenses | 16.57 Billion | 15.32 Billion | 12.58 Billion | 11.82 Billion | 12.87 Billion | 12.58 Billion |
| Operating Income | - | -1.5 Billion | -111.35 Million | 72.75 Million | -1.3 Billion | -1.36 Billion |
| Interest Expense | 226.61 Million | 173.12 Million | 50.2 Million | 44.68 Million | 71.2 Million | 70.39 Million |
| Income Tax Expense | 88.08 Million | 258.64 Million | -110.92 Million | 171.54 Million | 119.72 Million | -343.47 Million |
| Earnings before Tax | -616.66 Million | -1.76 Billion | 219.68 Million | 514.79 Million | -482.1 Million | -599.05 Million |
| Net Income | -704.74 Million | -2.02 Billion | 330.61 Million | 343.24 Million | -601.82 Million | -238 Million |
| Earnings Per Share Basic | -10.01 | -28.73 | 4.70 | 4.88 | -8.55 | -3.38 |
| Earnings Per Share Diluted | -10.01 | -28.73 | 4.68 | 4.88 | -8.55 | -3.38 |
| Weighted Average Shares Outstanding | 70.4 Million | 70.39 Million | 70.39 Million | 70.39 Million | 70.39 Million | 70.39 Million |
| Weighted Average Shares Outstanding (Diluted) | 70.4 Million | 70.39 Million | 70.39 Million | 70.39 Million | 70.39 Million | 70.39 Million |
| Gross Margin | 0.29 | 0.59 | 0.65 | 0.66 | 0.65 | 0.58 |
| EBIT Margin | 0.04 | -0.03 | 0.10 | 0.11 | 0.01 | 0.00 |
| Profit Margin | -0.04 | -0.15 | 0.03 | 0.03 | -0.05 | -0.02 |
| EBITDA | 742.35 Million | -466.67 Million | 1.18 Billion | 1.41 Billion | 404.93 Million | 149.18 Million |
| Earnings Before Tax Margin | - | -0.11 | -0.01 | 0.01 | -0.11 | -0.12 |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 4.46 Billion | 17.04 Billion | 4.31 Billion | 4.34 Billion | 4.15 Billion | 4.23 Billion |
| Cost of Revenue | 2.87 Billion | 11.7 Billion | 2.93 Billion | 1.66 Billion | 1.62 Billion | 1.68 Billion |
| Gross Profit | 1.59 Billion | 5.33 Billion | 1.38 Billion | 2.67 Billion | 2.52 Billion | 2.54 Billion |
| Operating Expenses | 1.43 Billion | 6.72 Billion | 2.65 Billion | 2.57 Billion | 2.73 Billion | 2.55 Billion |
| Selling, General and Administrative Expenses | 1.18 Billion | - | 1.17 Billion | 1.05 Billion | 1.18 Billion | 1.01 Billion |
| Research and Development Expenses | 257.13 Million | - | 225.75 Million | 262.33 Million | 290.33 Million | 268.24 Million |
| Other Expenses | 38.6 Million | -1.25 Billion | -1.25 Billion | 112.76 Million | 55.35 Million | 86.3 Million |
| Cost and Expenses | 4.31 Billion | 18.43 Billion | 5.59 Billion | 4.24 Billion | 4.36 Billion | 4.23 Billion |
| Operating Income | 151.71 Million | -1.38 Billion | -1.27 Billion | 215.33 Million | -151.56 Million | 78.77 Million |
| Interest Expense | 40.33 Million | 226.61 Million | 45.93 Million | 55.8 Million | 67.26 Million | 57.61 Million |
| Income Tax Expense | 57.42 Million | 88.08 Million | 34.4 Million | -222 Thousand | 26.05 Million | 27.84 Million |
| Earnings before Tax | 149.98 Million | -616.66 Million | -1.25 Billion | 839.68 Million | -218.82 Million | 21.16 Million |
| Net Income | 92.55 Million | -704.74 Million | -1.29 Billion | 839.9 Million | -244.87 Million | -6.68 Million |
| Earnings Per Share Basic | 1.31 | - | -18.37 | 11.93 | -3.48 | -0.09 |
| Earnings Per Share Diluted | 1.31 | - | -18.37 | 11.92 | -3.48 | -0.09 |
| Weighted Average Shares Outstanding | 70.4 Million | 70.39 Million | 70.39 Million | 70.39 Million | 70.39 Million | 70.39 Million |
| Weighted Average Shares Outstanding (Diluted) | 70.4 Million | 70.39 Million | 70.39 Million | 70.39 Million | 70.39 Million | 70.39 Million |
| Gross Margin | 0.36 | 0.31 | 0.32 | 0.62 | 0.61 | 0.60 |
| EBIT Margin | 0.10 | - | -0.23 | 0.11 | 0.03 | 0.09 |
| Profit Margin | 0.02 | -0.04 | -0.30 | 0.19 | -0.06 | -0.00 |
| EBITDA | 434.98 Million | - | -1 Billion | 493.91 Million | 142.98 Million | 366.48 Million |
| Earnings Before Tax Margin | 0.03 | -0.08 | -0.30 | 0.05 | -0.04 | 0.02 |
601012
MSEXP
ARYACAPM
EDVMF
ADN
HOVS